SEC Filings

Filing links are provided when reliable SEC filing data is available.

Recent Filings

Form	Filing Date	Accepted	Document
IRANNOTICE	Sep 3, 2026	Sep 3, 2026	View filing
10-Q	Sep 3, 2026	Sep 3, 2026	View filing
8-K	Sep 1, 2026	Sep 1, 2026	View filing
4	Aug 24, 2026	Aug 24, 2026	View filing
ARS	Aug 24, 2026	Aug 24, 2026	View filing
DEFA14A	Aug 17, 2026	Aug 17, 2026	View filing
DEF 14A	Aug 17, 2026	Aug 17, 2026	View filing
4	Aug 4, 2026	Aug 4, 2026	View filing
4	Aug 4, 2026	Aug 4, 2026	View filing
4	Aug 4, 2026	Aug 4, 2026	View filing
4	Aug 4, 2026	Aug 4, 2026	View filing
4	Aug 4, 2026	Aug 4, 2026	View filing
4	Aug 4, 2026	Aug 4, 2026	View filing
4	Aug 4, 2026	Aug 4, 2026	View filing
4	Aug 4, 2026	Aug 4, 2026	View filing
4	Jul 29, 2026	Jul 29, 2026	View filing
4	Jul 9, 2026	Jul 9, 2026	View filing
3	Jun 26, 2026	Jun 26, 2026	View filing
IRANNOTICE	Jun 18, 2026	Jun 18, 2026	View filing
10-K	Jun 18, 2026	Jun 18, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
4	Jun 8, 2026	Jun 8, 2026	View filing
4	Jun 8, 2026	Jun 8, 2026	View filing
4	Jun 8, 2026	Jun 8, 2026	View filing
4	Jun 8, 2026	Jun 8, 2026	View filing
4	Jun 8, 2026	Jun 8, 2026	View filing
8-K	Jun 3, 2026	Jun 3, 2026	View filing
4	May 28, 2026	May 28, 2026	View filing
4	May 28, 2026	May 28, 2026	View filing
4	May 28, 2026	May 28, 2026	View filing

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway, GA

95,000 employees

www.medtronic.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Geoffrey Straub Martha

View full financials